Article Details

Fosun, BioNTech in $200 Million China Vaccine Venture

Retrieved on: 2021-05-10 12:20:22

Tags for this article:

Click the tags to see associated articles and topics

Fosun, BioNTech in $200 Million China Vaccine Venture. View article details on hiswai:

Excerpt

Fosun Pharma announced it would set up a Shanghai facility to co-produce a Covid-19 vaccine developed by BioNTech SE for the China market, just ...

Article found on: www.caixinglobal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up